董事长专访 | 大洋生物陈阳贵：扎扎实实谋发展，矢志打造长青基业

Core Viewpoint - The company focuses on strengthening its core potassium salt business while simultaneously developing its two wings: veterinary medicine and fluorine fine chemicals, aiming for scale effects and sustainable growth [2][4]. Group 1: Company Development and Strategy - Since its establishment in 1976, the company has maintained a commitment to its core business, leveraging deep technical expertise and precise industry positioning to build a unique competitive advantage in niche markets [3][4]. - The company has optimized its supply chain by reducing reliance on upstream raw materials, achieving self-sufficiency in supply [4]. - The company emphasizes technological innovation and product competitiveness, which has propelled its scale development and solidified its global position in the potassium salt market [4][5]. Group 2: Financial Performance - In the first three quarters of 2025, the company achieved a revenue of 747 million yuan, representing a year-on-year growth of 11.24%, while net profit attributable to shareholders reached 80.04 million yuan, up 56.12% [5]. Group 3: Market Position and Product Development - The company holds nearly 50% market share in the global potassium bicarbonate market as of 2024, with its veterinary medicine product gaining traction in high-end markets in Europe and the United States [5]. - The company's potassium carbonate products are widely used in high-end sectors such as food, pharmaceuticals, and pesticides due to their superior characteristics [5]. Group 4: Historical Context and Challenges - The company faced significant challenges in the past, including a funding crisis due to over-optimistic market demand forecasts, but managed to recover through strategic capital increases and market channel expansion [6][7]. - The listing on the Shenzhen Stock Exchange in 2020 marked a pivotal moment, enabling the company to invest significantly in expanding production capacity [7]. Group 5: Future Outlook and Innovation - The company is actively pursuing cross-industry expansion, including investments in semiconductor materials and collaborations to enhance product applications in feed additives [9]. - The company is committed to continuous innovation and talent development, establishing itself as a national high-tech enterprise with various research platforms [9].